Cover Image

Systemic inflammation plays a key prognostic role in patients with head and neck cancer treated with immunotherapy and is linked to CT-based body composition metrics

To investigate the prognostic significance of pretreatment inflammatory markers and their association with computed tomography (CT)-based body composition (BC) metrics in patients with recurrent and/or metastatic head and neck squamous cell cancer (HNSCC) treated with immunotherapy.

Saved in:
Bibliographic Details
Main Authors: Jungbauer, Frederic (Author) , Ludwig, Sonja (Author) , Huber, Lena (Author) , Affolter, Annette (Author) , Lammert, Anne (Author) , Rotter, Nicole (Author) , Scherl, Claudia (Author) , Seiz, Elena (Author) , Vahidi Noghani, Farroch (Author) , Schönberg, Stefan (Author) , Haubold, Johannes (Author) , Arndt, Clara (Author) , Ludwig, Johannes Maximilian (Author)
Format: Article (Journal)
Language:English
Published: 15 March 2026
In: European archives of oto-rhino-laryngology and head & neck

ISSN:1434-4726
DOI:10.1007/s00405-026-10159-2
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s00405-026-10159-2
Get full text
Author Notes:Frederic Jungbauer, Sonja Ludwig, Lena Huber, Annette Affolter, Anne Lammert, Nicole Rotter, Claudia Scherl, Elena Seiz, Farroch Vahidi Noghani, Stefan O. Schönberg, Johannes Haubold, Clara Arndt, Johannes M. Ludwig
Description
Summary:To investigate the prognostic significance of pretreatment inflammatory markers and their association with computed tomography (CT)-based body composition (BC) metrics in patients with recurrent and/or metastatic head and neck squamous cell cancer (HNSCC) treated with immunotherapy.
Item Description:Gesehen am 31.03.2026
Physical Description:Online Resource
ISSN:1434-4726
DOI:10.1007/s00405-026-10159-2

Similar Items